Adapting the HITSystem to Support Prevention of Mother-to-child HIV Transmission
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | HIV / AIDS |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/28/2018 |
| Start Date: | August 2015 |
| End Date: | April 2019 |
The purpose of this study is to modify the HITSystem to engage and retain HIV+ pregnant women
before, during and after delivery and evaluate the HITSystem impact on prevention of
mother-to-child transmission (PMTCT) related behaviors and outcomes. HITSystem 2.0
intervention will support a range of PMTCT outcomes including retention in care, ART
adherence, and integration of maternal and pediatric HIV services in low-resource settings.
before, during and after delivery and evaluate the HITSystem impact on prevention of
mother-to-child transmission (PMTCT) related behaviors and outcomes. HITSystem 2.0
intervention will support a range of PMTCT outcomes including retention in care, ART
adherence, and integration of maternal and pediatric HIV services in low-resource settings.
The study will be conducted in three phases:
Phases 1: The researchers will conduct formative research (focus groups and interviews) with
HIV+ pregnant women and PMTCT providers to customize communication strategies for text
messaging and inform patient flow and optimal implementation across the various PMTCT-related
services at the intervention site.
Phase 2: The researchers will design and refine the HITSystem 2.0 technical components to
support PMTCT outcomes guided by clinical content experts, technology analysts, and findings
from Phase 1.
Phase 3: The researchers will implement HITSystem 2.0 at one hospital over an 18 month
period, and compare targeted PMTCT outcomes to those at a matched control hospital.
The study will be conducted at two government hospitals in Kenya. HIV+ pregnant women will be
enrolled in the HITSystem 2.0 at Kapsabet Hospital. HIV+ pregnant women receiving the current
standard of PMTCT care at Nandi Hills Hospital will be the comparison group.
Phases 1: The researchers will conduct formative research (focus groups and interviews) with
HIV+ pregnant women and PMTCT providers to customize communication strategies for text
messaging and inform patient flow and optimal implementation across the various PMTCT-related
services at the intervention site.
Phase 2: The researchers will design and refine the HITSystem 2.0 technical components to
support PMTCT outcomes guided by clinical content experts, technology analysts, and findings
from Phase 1.
Phase 3: The researchers will implement HITSystem 2.0 at one hospital over an 18 month
period, and compare targeted PMTCT outcomes to those at a matched control hospital.
The study will be conducted at two government hospitals in Kenya. HIV+ pregnant women will be
enrolled in the HITSystem 2.0 at Kapsabet Hospital. HIV+ pregnant women receiving the current
standard of PMTCT care at Nandi Hills Hospital will be the comparison group.
Phase 3
Inclusion Criteria:
- HIV+ pregnant women
- Present for first PMTCT appointment at one of the study Hospitals
- Own or have reliable access to mobile phone
Exclusion Criteria:
We found this trial at
2
sites
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
Click here to add this to my saved trials
Click here to add this to my saved trials